نتائج البحث

Association of CTLA-4 Polymorphisms with Improved Overall Survival in Melanoma Patients Treated with CTLA-4 Blockade: A Pilot Study.

• Authors : Queirolo, P.¹ (AUTHOR); Morabito, A.² (AUTHOR) ; Laurent, S.³ (AUTHOR)

• Source: Cancer Investigation. Jun2013, Vol. 31 Issue 5, p336-345. 10p. 6 Charts, 2 Graphs.

تفاصيل العنوان

Temporal Trends of HLA, CTLA-4 and PTPN22 Genotype Frequencies among Type 1 Diabetes in Continental Italy.

• Authors : Spoletini, Marialuisa¹; Zampetti, Simona¹; Campagna, Giuseppe¹

Subjects: *HLA histocompatibility antigens; *Cytotoxic T lymphocyte-associated molecule-4; *Type 1 diabetesItaly

• Source: PLoS ONE. Apr2013, Vol. 8 Issue 4, p1-5. 5p.

تفاصيل العنوان

Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients.

• Authors : Valenti L; Department of Internal Medicine, University of Milan, Policlinico Hospital IRCCS, Italy.; De Feo T

Subjects: Adenine* ; Guanine*; Antigens, Differentiation/Antigens, Differentiation/Antigens, Differentiation/*genetics

• Source: Alcohol and alcoholism (Oxford, Oxfordshire) [Alcohol Alcohol] 2004 Jul-Aug; Vol. 39 (4), pp. 276-80.Publisher: Oxford University Press Country of Publication: England NLM ID: 8310684 Publication Model: Print Cited Medium: Print ISSN: 0735-0414

تفاصيل العنوان

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice.

• Authors : Giannini, Edoardo G.¹ (AUTHOR) ; Aglitti, Andrea² (AUTHOR); Borzio, Mauro³ (AUTHOR)

• Source: Cancers. Nov2019, Vol. 11 Issue 11, p1689-1689. 1p.

تفاصيل العنوان

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy).

• Authors : Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Naples, Italy. .; Agarwala SS

Subjects: Melanoma*/Melanoma*/Melanoma*/therapy ; Melanoma*/Melanoma*/Melanoma*/drug therapy; Humans

• Source: Journal of translational medicine [J Transl Med] 2023 Jul 28; Vol. 21 (1), pp. 508. Date of Electronic Publication: 2023 Jul 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).

• Authors : Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 80131, Naples, Italy. .; Puzanov I

Subjects: Immunotherapy* ; Melanoma*/Melanoma*/Melanoma*/therapy; CTLA-4 Antigen

• Source: Journal of translational medicine [J Transl Med] 2020 Sep 07; Vol. 18 (1), pp. 346. Date of Electronic Publication: 2020 Sep 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

The great debate at "Melanoma Bridge 2018", Naples, December 1st, 2018.

• Authors : Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Via Mariano Semmola, 80131, Naples, Italy. .; Bruzzi P

Subjects: Melanoma/Melanoma/Melanoma/*pathology; CTLA-4 Antigen/CTLA-4 Antigen/CTLA-4 Antigen/metabolism ; Chemotherapy, Adjuvant

• Source: Journal of translational medicine [J Transl Med] 2019 May 10; Vol. 17 (1), pp. 148. Date of Electronic Publication: 2019 May 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان